Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Other financing activities (2016 - 2026)

Healthstream has reported Other financing activities over the past 12 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Other financing activities rose 629.28% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 126.06% year-over-year, with the annual reading at $2.5 million for FY2025, 126.06% up from the prior year.
  • Other financing activities was $1.3 million for Q4 2025 at Healthstream, up from $121000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.3 million in Q4 2025 and troughed at -$711000.0 in Q4 2021.
  • The 5-year median for Other financing activities is $20000.0 (2023), against an average of $207684.2.
  • The largest YoY upside for Other financing activities was 700.0% in 2023 against a maximum downside of 89.2% in 2023.
  • A 5-year view of Other financing activities shows it stood at -$711000.0 in 2021, then skyrocketed by 252.32% to $1.1 million in 2022, then crashed by 89.2% to $117000.0 in 2023, then soared by 54.7% to $181000.0 in 2024, then skyrocketed by 629.28% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Other financing activities are $1.3 million (Q4 2025), $121000.0 (Q3 2025), and $5000.0 (Q2 2025).